GlobeImmune Inc (NASDAQ:GBIM)

7.40
Delayed Data
As of Mar 27
 +0.28 / +3.93%
Today’s Change
4.29
Today|||52-Week Range
15.00
-2.50%
Year-to-Date
No recent news for GlobeImmune Inc.

Today’s Trading

Previous close7.12
Today’s open7.23
Day’s range7.05 - 7.83
Volume24,172
Average volume (3 months)26,910
Market cap$42.6M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-572.52%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-73.50%
P/E ratioNM
Price/Sales3.71
Price/Book7.60

Competitors

 Today’s
change
Today’s
% change
GBSNUGreat Basin Scientif...+0.20+1.92%
TROVUTrovagene Inc0.000.00%
INISInternational Isotop...+0.01+17.25%
APPYVenaxis Inc-0.01-2.17%
Data as of 3:56pm ET, 03/27/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$6.0M
Annual profit (last year)-$16.3M
Net profit margin-272.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Timothy C. Rodell
Secretary, Treasurer &
Vice President-Finance
C. Jeffrey Dekker
Corporate headquarters
Louisville, Colorado

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account